RSBG

RSBG SE is a German industrial holding and investment company, acting as a wholly owned subsidiary of the RAG-Stiftung, based in Essen. Established in 2014, the firm focuses on long-term investments in high-growth technology sectors, prominently including pharmaceuticals and life sciences, along with robotics, automation, and infrastructure. RSBG manages a global portfolio of over 85 companies with more than 12,500 employees, employing a systematic "buy-and-build" strategy to develop market-leading specialists in niches such as pharmaceutical engineering and medtech. Notable healthcare-related investments have included the United Robotics Group and Scewo, and the firm previously built the Masco Group into a global biopharma engineering leader before selling its majority stake in 2024. The company's earnings contribute to financing the perpetual environmental and social obligations resulting from Germany's former hard coal mining industry.